Pancreatic Cancer Research

ResearcherFirst Hospital of China Medical UniversityNo recent work listed

Kewei Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3816-1024; OpenAlex author ID A5100622681. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper

Papers 2

  1. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer. Co-author DOI 10.1096/fj.201601240r↗
  2. Expression of vitamin D receptor as a potential prognostic factor and therapeutic target in pancreatic cancer. Co-author DOI 10.1111/his.12663↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Weiwei Sheng · 2 shared papers, 2015–2017 · strength 0.13
  2. Ming Dong · 2 shared papers, 2015–2017 · strength 0.13
  3. Jianping Zhou · 1 shared paper, 2017 · strength 0.07
  4. Yuji Li · 1 shared paper, 2017 · strength 0.07
  5. Yunwei Li · 1 shared paper, 2017 · strength 0.07
  6. Qingchang Li · 1 shared paper, 2015 · strength 0.05
  7. Junqiang Wang · 1 shared paper, 2015 · strength 0.05
  8. Qingfeng Liu · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.